Experienced meditators exhibit no differences to demographically-matched controls in theta phase synchronisation, P200, or P300 during an auditory oddball task

Payne, J. R.; Baell, O.; Geddes, H.; Fitzgibbon, B.; Emonson, M.; Hill, A. T.; Van Dam, N. T.; Humble, G.; Fitzgerald, P. B.; Bailey, N. W.

doi:10.1101/608547

bioRxiv · 10.1101/608547

Experienced meditators exhibit no differences to demographically-matched controls in theta phase synchronisation, P200, or P300 during an auditory oddball task

Payne, J. R.·Baell, O.·Geddes, H.·Fitzgibbon, B.·Emonson, M.·Hill, A. T.·Van Dam, N. T.·Humble, G.·Fitzgerald, P. B.·Bailey, N. W.

View original source ↗Export metadata ↓

Abstract

ObjectivesLong-term meditation practice affects the brains ability to sustain attention. However, how this occurs is not well understood. Electroencephalography (EEG) studies have found that during dichotic oddball listening tasks, experienced meditators displayed altered attention-related neural markers including theta phase synchronisation (TPS) and event-related potentials (ERP; P200 and P300) to target tones while meditating compared to resting, and compared to non-meditators after intensive meditation interventions. Research is yet to establish whether the changes in the aforementioned neural markers are trait changes which may be observable in meditators irrespective of practice setting.\n\nMethodThe present study expanded on previous research by comparing EEG measures from a dichotic oddball task in a sample of community-based mindfulness meditators (n=22) to healthy controls with no meditation experience (n=22). To minimise state effects, neither group practiced meditation during / immediately prior to the EEG session.\n\nResultsNo group differences were observed in behavioural performance or either the global amplitude or distribution of theta phase synchronisation, P200 or P300. Bayes Factor analysis suggested evidence against group differences for the P200 and P300.\n\nConclusionsThe results suggest that increased P200, P300 and TPS do not reflect trait-related changes in a community sample of mindfulness meditators. The present study used a larger sample size than previous research and power analayses suggested the study was suficiently powered to detect differences. These results add nuance to our understanding of which processes are affected by meditation and the amount of meditation required to generate differences in specific neural processes.

Source connections

Published article ↗

Explore related subjects

neuroscience Preprint

Keep this discovery

Explore connections, maps & timelines

BibTeX RIS

Payne, J. R., Baell, O., Geddes, H., Fitzgibbon, B., Emonson, M., Hill, A. T., Van Dam, N. T., Humble, G., Fitzgerald, P. B., Bailey, N. W.. 2019-04-14. Experienced meditators exhibit no differences to demographically-matched controls in theta phase synchronisation, P200, or P300 during an auditory oddball task. https://doi.org/10.1101/608547

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

bioRxiv2026

The Unreasonable Effectiveness of Cell Types in Describing Neuronal Physiological Features

Single-cell RNA sequencing (scRNA-seq) captures detailed gene expression profiles at scale, while patch-clamp recordings measure intrinsic neuronal electrophysiological properties. Modeling the relations between these two modalities remains a challenge. Here, we compare how well electrophysiological features can be predicted by traditional transcriptomic cell type classification, representations derived from a foundational model (scGPT) pretrained on large-scale scRNA-seq datasets, ion channel-coding genes, and highly variable genes. Using paired transcriptomic and electrophysiological patch-sequencing data from 495 human neurons from neurosurgical tissue, we find that cluster-level cell type representations consistently outperform highly variable gene selection, ion channel gene selection, and context-enriched scGPT embeddings. Notably, performance varies across model architectures and initializations, and the best results are obtained by combining the outputs of separate cell type and scGPT-based models. Together, these findings suggest that traditional discrete cellular classification is highly effective in predicting physiological features. For maximum performance it can be complemented by pretrained transformer models.

neuroscience↗

bioRxiv2026

A nonlinear inhibition pathway underlying cortical responses to tuned holographic optogenetic perturbations

Optogenetics enables causal manipulation of cortical activity. Perturbation responses can be counterintuitive due to network interactions, making theory essential for predicting them. Existing approaches often rely on linear approximations, which fail for many biologically relevant perturbations. Here we develop a nonlinear theory of responses to holographic perturbations in cell-type-specific recurrent networks with structured connectivity. We fit a nonlinear model to mouse V1 data, which shows cotuned-ensemble suppression: perturbing spatially clustered neurons with similar preferred orientations yields markedly stronger short-range suppression than perturbing untuned ensembles. We show that cotuned-ensemble suppression arises from a feature-tuned, nonlinear inhibition pathway implicating somatostatin-positive (SST) interneurons. The theory predicts that cotuned ensembles suppress parvalbumin-positive (PV) neurons but facilitate SST neurons, and links the degree of cotuned-ensemble suppression or facilitation to the variance of the SST response. This framework identifies mechanisms by which nonlinear inhibition sculpts cortical dynamics and establishes a predictive basis for targeted optogenetic interventions.

neuroscience↗

bioRxiv2026

Proteomic signatures of APOE ε4 across human tissues and cell types in Alzheimers disease

The apolipoprotein E {varepsilon}4 (APOE {varepsilon}4) allele is the strongest genetic risk factor for late-onset Alzheimers disease (AD). However, the underlying molecular mechanisms remain unclear. This study included 1691 participants from the Religious Orders Study and Rush Memory and Aging Project (ROSMAP), 1226 participants from the Accelerating Medicines Partnership - Alzheimers Disease (AMP-AD) Diverse Cohorts Study, and 735 participants from the Alzheimers Disease Neuroimaging Initiative (ADNI). To characterise APOE {varepsilon}4 molecular effects, we analysed proteomic data from plasma, cerebrospinal fluid (CSF), and induced pluripotent stem cell (iPSC)-derived astrocytes and neurons, as well as transcriptomic and proteomic data from multiple brain regions. The association of APOE {varepsilon}4 with AD neuropathology was also examined. APOE {varepsilon}4 carriers shared a plasma proteomic signature enriched for immune processes, irrespective of AD diagnosis. A machine learning classifier trained on this signature discriminated APOE {varepsilon}4 carriers from non-carriers in an independent cohort using CSF proteomics. APOE {varepsilon}4 carriage was associated with higher Braak stages and Consortium to Establish a Registry for Alzheimers Disease (CERAD) score. However, only limited APOE {varepsilon}4-associated transcriptomic and proteomic changes were observed in bulk brain tissue, with poor cross-layer concordance. Proteomic analyses of iPSC-derived astrocytes and neurons further revealed cell-type-specific APOE {varepsilon}4-associated changes. APOE {varepsilon}4 is associated with a consistent proteomic signature across plasma and CSF. Its molecular effects in the brain differ across cell types, brain regions and molecular layers. These findings support the need for cell-type-resolved multi-omic studies to elucidate how APOE {varepsilon}4 confers AD risk.

neuroscience↗